Global Biologics and Biosimilars Industry 2016 Deep Market Research Report
- QYR431413
- 188 Pages
- March 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biologics and Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 292 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Biologics and Biosimilars Industry Report 2016 1
1 Industry Overview 1
1.1 Definition and Specifications of Biologics and Biosimilars 1
1.1.1 Definition of Biologics and Biosimilars 1
1.1.2 Specifications of Biologics and Biosimilars 2
1.2 Classification of Biologics and Biosimilars 4
1.3 Applications of Biologics and Biosimilars 4
1.4 Industry Chain Structure of Biologics and Biosimilars 5
1.5 Industry Overview and Major Regjions Status of Biologics and Biosimilars 6
1.5.1 Industry Overview of Biologics and Biosimilars 6
1.5.2 Global Major Regions Status of Biologics and Biosimilars 7
1.6 Industry Policy Analysis of Biologics and Biosimilars 7
1.7 Industry News Analysis of Biologics and Biosimilars 8
2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars 10
2.1 Labor Cost Analysis of Biologics and Biosimilars 10
2.2 Other Costs Analysis of Biologics and Biosimilars 14
2.3 Manufacturing Cost Structure Analysis of Biologics and Biosimilars 15
2.4 Manufacturing Process Analysis of Biologics and Biosimilars 15
2.5 Global Gross of Biologics and Biosimilars 2011-2016 17
3 Technical Data and Manufacturing Plants Analysis of Biologics and Biosimilars 18
3.1 Revenue and Commercial Production Date of Global Key Manufacturers in 2014 18
3.2 R&D Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014 19
4 Production Analysis of Biologics by Regions and Types 20
4.1 Global Production of Biologics by Regions 2011-2016 20
4.2 Global Production of Biologics by Type 2011-2016 23
4.3 Global and Major Regions Revenue and Growth Rate of Biologics 2011-2016 27
4.4 Global and Major Manufacturers Revenue (M USD) of Biologics 2011-2016 29
5 Production Analysis of Biosimilars by Regions, Types 33
5.1 Global Production of Biosimilars by Regions 2011-2016 33
5.2 Global and Major Regions Revenue and Growth Rate of Biosimilars 2011-2016 36
5.3 Global and Major Manufacturers Revenue (M USD) of Biologics 2011-2016 39
6 Consumption Value Analysis of Biologics and Biosimilars by Regions and Applications 42
6.1 Global Consumption Value of Biologics by Regions 2011-2016 42
6.2 Global and Major Regions Consumption Value and Growth Rate of Biologics 2011-2016 45
6.3 Global Consumption Value of Biosimilars by Regions 2011-2016 47
6.4 Global and Major Regions Consumption Value and Growth Rate of Biosimilars 2011-2016 51
6.5 Global Consumption Value of Biologics and Biosimilars by Applications 2011-2016 53
7 Supply, Consumption Analysis of Biologics and Biosimilars 57
7.1 Supply, Consumption and Gap of Biologics 2011-2016 57
7.2 Supply, Consumption and Gap of Biosimilars 2011-2016 58
7.3 Global Cost, Revenue of Biologics and Biosimilars 2011-2016 59
7.4 America Cost, Revenue of Biologics and Biosimilars 2011-2016 59
7.5 Europe Cost, Revenue of Biologics and Biosimilars 2011-2016 60
7.6 India Cost, Revenue of Biologics and Biosimilars 2011-2016 60
7.7 China, Cost, Revenue of Biologics and Biosimilars 2011-2016 60
8 Key Manufacturers Analysis of Biologics and Biosimilars Industry 61
Biologics 61
8.1 Roche 61
8.1.1 Company Profile 61
8.1.2 Product Picture and Specifications 62
8.1.3 Cost, Gross, and Revenue 63
8.1.4 Contact Information 64
8.2 Amgen 64
8.2.1 Company Profile 64
8.2.2 Product Picture 65
8.2.3 Cost, Gross, and Revenue 66
8.2.4 Contact Information 67
8.3 AbbVie 67
8.3.1 Company Profile 67
8.3.2 Product Picture and Specifications 69
8.3.3 Cost, Gross, and Revenue 69
8.3.4 Contact Information 70
8.4 Sanofi-Aventis 71
8.4.1 Sanofi-Aventis Company Profile 71
8.4.2 Product Picture and Specifications 72
8.4.3 Cost, Gross, and Revenue 72
8.4.4 Contact Information 73
8.5 Johnson & Johnson 73
8.5.1 Company Profile 73
8.5.2 Product Picture 75
8.5.3 Cost, Gross, and Revenue 75
8.5.4 Contact Information 76
8.6 Pfizer 77
8.6.1 Company Profile 77
8.6.2 Product Picture 79
8.6.3 Cost, Gross, and Revenue 80
8.6.4 Contact Information 81
8.7 Novo Nordisk 81
8.7.1 Company Profile 81
8.7.2 Product Picture 82
8.7.3 Cost, Gross, and Revenue 83
8.7.4 Contact Information 84
8.8 Eli Lilly 84
8.8.1 Eli Lilly 84
8.8.2 Product Picture 85
8.8.3 Cost, Gross, and Revenue 85
8.8.4 Contact Information 86
8.9 Novartis 87
8.9.1 Novartis Company Profile 87
8.9.2 Product Picture and Specifications 88
8.9.3 Cost, Gross, and Revenue 88
8.9.4 Contact Information 90
8.10 Merck 90
8.10.1 Merck 90
8.10.2 Product Picture and Specifications 91
8.10.3 Cost, Gross, and Revenue 91
8.10.4 Contact Information 92
8.11 Sun pharma 93
8.11.1 Sun pharma Company Profile 93
8.11.2 Product Picture and Specifications 94
8.11.3 Cost, Gross, and Revenue 94
8.11.4 Contact Information 95
8.12 3sbio 96
8.12.1 3sbio Company Profile 96
8.12.2 Product Picture 97
8.12.3 Cost, Gross, and Revenue 97
8.12.4 Contact Information 98
8.13 Changchun High Tech 98
8.13.1 Changchun High Tech Company Profile 98
8.13.2 Product Picture 99
8.13.3 Cost, Gross, and Revenue 99
8.13.4 Contact Information 100
8.14 CP Guojian Pharmacy 101
8.14.1 CP Guojian Pharmacy 101
7.14.2 Product Picture 102
8.14.3 Cost, Gross, and Revenue 102
8.14.4 Contact Information 103
8.15 Biotech Pharma 103
8.15.1 Biotech Pharma 103
8.15.2 Product Picture 104
8.15.3 Cost, Gross, and Revenue 105
8.15.4 Contact Information 106
8.16 Gelgen Biopharma 106
8.16.1 Gelgen Biopharma 106
8.16.2 Product Picture 107
8.16.3 Cost, Gross, and Revenue 108
8.16.4 Contact Information 109
8.17 Innovent 109
8.17.1 Innovent 109
8.17.2 Product Picture 110
8.17.3 Cost, Gross, and Revenue 111
8.17.4 Contact Information 112
8.18 Tong Hua Dong Bao Group 112
8.18.1 Company Profile 112
8.18.2 Product Picture 113
8.18.3 Cost, Gross, and Revenue 113
8.18.4 Contact Information 114
8.19 Ganlee 115
8.19.1 Company Profile 115
8.19.2 Product Picture 115
8.19.3 Cost, Gross, and Revenue 116
8.19.4 Contact Information 117
8.20 United Laboratories 117
8.20.1 United Laboratories Company Profile 117
8.20.2 Product Picture and Specifications 119
8.20.3 Cost, Gross, and Revenue 119
8.20.4 Contact Information 120
Biosimilar 121
8.1 SANDOZ (NOVARTIS) 121
8.1.1 Company Profile 121
8.1.2 Product Picture and Specifications 122
8.1.3 Cost, Gross, and Revenue 122
7.1.4 Contact Information 123
8.2 Teva Pharmaceutical 124
8.2.1 Company Profile 124
8.2.2 Product Picture and Specifications 125
8.2.3 Cost, Gross, and Revenue 125
8.2.4 Contact Information 126
8.3 Hospira -Pfizer- 126
8.3.1 Company Profile 126
8.3.2 Product Picture and Specifications 128
8.3.3 Cost, Gross, and Revenue 128
8.3.4 Contact Information 129
8.4 MYLAN 130
8.4.1 Company Profile 130
8.4.2 Product Picture and Specifications 131
8.4.3 Cost, Gross, and Revenue 131
8.4.4 Contact Information 132
8.5 Sun pharma 133
8.5.1 Sun Pharma Company Profile 133
8.5.2 Product Picture and Specifications 134
8.5.3 Cost, Gross, and Revenue 134
8.5.4 Contact Information 135
8.6 3sbio 136
8.6.1 3sbio Company Profile 136
8.6.2 Product Picture 137
8.6.3 Cost, Gross, and Revenue 137
8.6.4 Contact Information 138
8.7 Changchun High Tech 138
8.7.1 Changchun High Tech Company Profile 138
8.7.2 Product Picture 139
8.7.3 Cost, Gross, and Revenue 139
8.6.4 Contact Information 141
8.8 CP Guojian Pharmacy 141
8.8.1 CP Guojian Pharmacy 141
8.8.2 Product Picture 142
8.8.3 Cost, Gross, and Revenue 142
8.8.4 Contact Information 143
8.9 Biotech Pharma 144
8.9.1 Biotech Pharma 144
8.9.2 Product Picture 145
8.9.3 Cost, Gross, and Revenue 145
8.9.4 Contact Information 146
8.10 Gelgen Biopharma 147
8.10.1 Gelgen Biopharma 147
8.10.2 Product Picture 148
8.10.3 Cost, Gross, and Revenue 148
8.10.4 Contact Information 149
9 Marketing Trader or Distributor Analysis of Biologics and Biosimilars 150
9.1 Biologics and Biosimilars Marketing Channels Status 150
9.2 Traders or Distributors of Biologics and Biosimilars with Contact Information 151
9.3.1 Supply, Consumption and Gap of Biologics 2011-2016 152
9.3.2 Supply, Consumption and Gap of Biosimilars 2011-2016 153
10 Industry Chain Suppliers with Contact Information of Biologics and Biosimilars 155
10.1 Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information 155
10.2 Major Suppliers of Biologicas and Biosimilars with Contact Information 155
10.3 Key Consumers of Biologicas and Biosimilars with Contact Information 156
10.4 Supply Chain Relationship Analysis of Biologics and Biosimilars 157
11 Development Trend of Biologics and Biosimilars Industry 2016-2021 158
11.1 Capacity and Production Overview of Biologics and Biosimilars 2016-2021 158
11.2 Production Market Share Analysis of Biologics and Biosimilars 2016-2021 159
11.3 Sales Overview of Biologics and Biosimilars 2016-2021 161
11.4 Supply, Sales, and Gap of Biologics and Biosimilars 2016-2021 162
11.5 Cost, Revenue and Gross Margin of Biologics and Biosimilars 2016-2021 163
12 New Project Investment Feasibility Analysis of Biologics and Biosimilars 164
12.1 New Project SWOT Analysis of Biologics and Biosimilars 164
12.2 New Project Investment Feasibility Analysis of Biologics and Biosimilars 164
13 Conclusion of the Global Biologics and Biosimilars Industry Report 2016 166
Figure Biologics and Biosimilars Product Picture 1
Figure Biologics and Biosimilars Product Picture 2
Table Specifications of Biologics and Biosimilars 2
Table Classification of Biologics and Biosimilars 4
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015 4
Table Application Fields of Biologics and Biosimilars Products 4
Figure 2014 Global Biologics and Biosimilars Major Applications Sales Share 5
Figure Industry Chain Structure of Biologics and Biosimilars 5
Table Industry Policy of Biologics and Biosimilars 7
Figure 2014 Global FOB Policy and Regulations 8
Table Industry News List of Biologics and Biosimilars 8
Figure 2014 APAC Overview of Average Monthly Labor Cost 10
Figure 2014 Americas Overview of Average Monthly Labor Cost 11
Figure 2014 EMEA Overview of Average Monthly Labor Cost 11
Figure 2011-2016 USA Quarterly Employment Cost Index (ECI) 12
Figure 2011-2016 EU Quarterly Labor Cost Index 12
Figure 2011-2016 Japan Yearly Manufacturing Cash Earnings and Growth Rate 13
Table 2014 Global Electricity Price of Resident and Industry (USD/Kw-h) by Country 14
Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2014 15
Figure Production Flow Chart of Mammalian Cell Expression System Producing Line 15
Figure Production Flow Chart of Bacterial cell expression system Producing Line 15
Figure Biologics and Biosimilars Marketing Process 16
Figure Global Gross Analysis of Biologics and Biosimilars 2011-2016 16
Table Revenue (M USD) and Commercial Production Date of Global Biologics and Biosimilars Key Manufacturers in 2014 17
Table R&D Status and Technology Source of Global Biologics and Biosimilars Key Manufacturers in 2014 18
Table Global of Biologics by Regions 2011-2016 (M USD) 19
Figure Global Sales Market Share of Biologics by Regions in 2010 19
Figure Global Production Market Share of Biologics by Regions in 2011 20
Figure Global Production Market Share of Biologics by Regions in 2012 20
Figure Global Production Market Share of Biologics by Regions in 2013 21
Figure Global Production Market Share of Biologics by Regions in 2014 21
Figure Global Production Market Share of Biologics by Regions in 2015 22
Table Global Production of Biosimilars by Regions 2011-2016 (M USD) 22
Figure Global Production Market Share of Biosimilars by Regions in 2010 23
Figure Global Production Market Share of Biosimilars by Regions in 2011 23
Figure Global Production Market Share of Biosimilars by Regions in 2012 24
Figure Global Production Market Share of Biosimilars by Regions in 2013 24
Figure Global Production Market Share of Biosimilars by Regions in 2014 25
Figure Global Production Market Share of Biosimilars by Regions in 2015 25
Table Global Production of Biologics and Biosimilars by Type 2011-2016 (K Units) 25
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2014 26
Table Global Production of Biologics and Biosimilars by Applications 2011-2016 (M USD) 26
Figure Global Production Market Share of Biologics and Biosimilars by Applications in 2014 27
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2011-2016 28
Table US Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD) 28
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of US 2011-2016 28
Table US Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD) 28
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016 29
Table EU Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD) 29
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016 29
Table EU Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD) 29
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of EU 2011-2016 30
Table EU Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD) 30
Table China Supply, Import, Export and Consumption of Biologics 2011-2016 (M USD) 32
Table China Supply, Import, Export and Consumption of Biosimilars 2011-2016 (M USD) 32
Table Global Consumption Volume of Biologics by Regions 2011-2016 (M USD) 33
Figure Global Consumption Volume of Biologics by Regions in 2010 (M USD) 33
Figure Global Consumption Volume of Biologics by Regions in 2011 (M USD) 34
Figure Global Consumption Volume of Biologics by Regions in 2012 (M USD) 34
Figure Global Consumption Volume of Biologics by Regions in 2013 (M USD) 35
Figure Global Consumption Volume of Biologics by Regions in 2014 (M USD) 35
Figure Global Consumption Volume of Biologics by Regions in 2015 (M USD) 36
Table Global Consumption Value of Biosimilars by Regions 2011-2016 (M USD) 36
Figure Global Consumption Value of Biosimilars by Regions in 2010 (M USD) 37
Figure Global Consumption Value of Biosimilars by Regions in 2011 (M USD) 37
Figure Global Consumption Value of Biosimilars by Regions in 2012 (M USD) 38
Figure Global Consumption Value of Biosimilars by Regions in 2013 (M USD) 38
Figure Global Consumption Value of Biosimilars by Regions in 2014 (M USD) 39
Figure Global Consumption Value and Biosimilars by Regions in 2015 (M USD) 39
Table Global and Major Manufacturers Revenue of Biologics 2011-2016 (M USD) 40
Table Global and Major Manufacturers Revenue Market Share of Biologics 2011-2016 (M USD) 41
Figure Global Market Share of Major Biologics Manufacturers in 2010 42
Figure Global Market Share of Major Biologics Manufacturers in 2011 43
Figure Global Market Share of Major Biologics Manufacturers in 2012 44
Figure Global Market Share of Major Biologics Manufacturers in 2013 45
Figure Global Market Share of Major Biologics Manufacturers in 2014 46
Figure Global Market Share of Major Biologics Manufacturers in 2015 47
Table China Major Manufacturers Revenue of Major Biologics Manufacturers in 2011-2016 47
Table China Major Manufacturers Revenue Market Share of Major Biologics Manufacturers in 2011-2016 48
Figure China Revenue Market Share of Major Biologics Manufacturers in 2010 48
Figure China Revenue Market Share of Major Biologics Manufacturers in 2011 49
Figure China Revenue Market Share of Major Biologics Manufacturers in 2012 49
Figure China Revenue Market Share of Major Biologics Manufacturers in 2013 50
Figure China Revenue Market Share of Major Biologics Manufacturers in 2014 50
Figure China Revenue Market Share of Major Biologics Manufacturers in 2015 51
Table Global and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD) 51
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2011-2016 52
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2010 52
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011 53
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2012 53
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013 54
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014 54
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015 55
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016 55
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016 55
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2010 56
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2011 56
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2012 57
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2013 57
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2014 58
Figure China Revenue Market Share of Major Biosimilars Manufacturers in 2015 58
Figure Global Sales (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016 59
Figure China Sales (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016 59
Table Global Supply, Sales and Gap of Biologics 2011-2016 (M USD) 60
Table Global Supply, Sales and Gap of Biosimilars 2011-2016 (M USD) 60
Table China Supply, Sales and Gap of Biologics 2011-2016 (M USD) 60
Table China Supply, Sales and Gap of Biosimilars 2011-2016 (M USD) 60
Table China Import, Export and Consumption of Biologics 2011-2016 (M USD) 60
Table China Import, Export and Consumption of Biosimilars 2011-2016 (M USD) 61
Table Gross Margin of Global Biologics and Biosimilars Major Manufacturers 2011-2016 61
Figure Gross Margin of Global Biologics and Biosimilars Major Manufacturers in 2014 62
Table Global and Major Manufacturers Revenue of Biologics 2011-2016 (M USD) 62
Table Global and Major Manufacturers Revenue Market Share of Biologics 2011-2016 (M USD) 63
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2010 64
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2011 65
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2012 66
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2013 67
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2014 68
Figure Global Revenue Market Share of Major Biologics Manufacturers in 2015 69
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016 69
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016 70
Table Global and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD) 70
Table Global and Major Manufacturers Revenue Market Share of Biosimilars 2011-2016 (M USD) 70
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2010 71
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2011 71
Figure Global Revenue Market Share of Major Biosimilars and Biosimilars Manufacturers in 2012 72
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2013 72
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2014 73
Figure Global Revenue Market Share of Major Biosimilars Manufacturers in 2015 73
Table China Major Manufacturers Revenue of Major Biosimilars Manufacturers in 2011-2016 73
Table China Major Manufacturers Revenue Market Share of Major Biosimilars Manufacturers in 2011-2016 74
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2011-2016 74
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics 2011-2016 74
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016 74
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016 75
Table Roche Company Profile 76
Figure Biologics and Biosimilars Picture of Roche 77
Table Biologics and Biosimilars Specifications of Roche 77
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Roche 2011-2016 78
Figure Biologics Revenue (M USD) and Growth Rate of Roche 2011-2016 78
Figure Roche Biologics Revenue (M USD) and Global Market Share of 2011-2016 79
Table Amgen Company Profile 79
Figure Neulasta of Amgen 80
Figure Neupogen of Amgen 81
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Amgen 2011-2016 81
Figure Biologics Revenue (M USD) and Growth Rate of Amgen 2011-2016 81
Figure Biologics Revenue (M USD) and Global Market Share of Amgen 2011-2016 82
Table AbbVie Profile with Contact Information, Plant Location, Capacity, Revenue 82
Figure Humira of AbbVie 84
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of AbbVie 2011-2016 84
Figure Biologics Revenue (M USD) and Growth Rate of AbbVie 2011-2016 85
Figure Biologics Revenue (M USD) and Global Market Share of AbbVie 2011-2016 85
Table Sanofi-Aventis Company Profile with Contact Information, Plant Location, Capacity, Revenue 86
Figure Insulin of Sanofi-Aventis 87
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2011-2016 87
Figure Biologics Revenue (M USD) and Growth Rate of Sanofi-Aventis 2011-2016 87
Figure Biologics Revenue (M USD) and Global Market Share of Sanofi-Aventis 2011-2016 88
Table Johnson & Johnson Company Profile with Contact Information, Plant Location, Capacity, Revenue. 88
Table Epoetin alfa of Johnson & Johnson 90
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016 90
Figure Biologics Revenue (M USD) and Growth Rate of Johnson & Johnson 2011-2016 91
Figure Biologics Revenue (M USD) and Global Market Share of Johnson & Johnson 2011-2016 91
Table Pfizer Profile with Contact Information, Plant Location, Capacity, Revenue 92
Figure recombinant factor of Pfizer 94
Figure recombinant factor IX of Pfizer 94
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Pfizer 2011-2016 95
Figure Biologics Revenue (M USD) and Growth Rate of Pfizer 2011-2016 95
Figure Biologics Revenue (M USD) and Global Market Share Pfizer of 2011-2016 96
Table Novo Nordisk Company Profile with Contact Information, Plant Location, Capacity, Revenue 96
Figure Insulin of Novo Nordisk 97
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016 98
Figure Biologics Revenue (M USD) and Growth Rate of Novo Nordisk 2011-2016 98
Figure Biologics Revenue (M USD) and Global Market Share of Novo Nordisk 2011-2016 99
Table Eli Lilly Company Profile with Contact Information, Plant Location, Capacity, Revenue 99
Figure Insulin of Eli Lilly 100
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016 100
Figure Biologics Revenue (M USD) and Growth Rate of Eli Lilly 2011-2016 101
Figure Biologics Revenue (M USD) and Global Market Share of Eli Lilly 2011-2016 101
Table Novartis Company Profile with Contact Information, Plant Location, Capacity, Revenue 102
Figure of atumumab of Novartis 103
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Novartis 2011-2016 104
Figure Biologics Revenue (M USD) and Growth Rate of Novartis 2011-2016 104
Figure Biologics Revenue (M USD) and Global Market Share of Novartis 2011-2016 105
Table Merck Company Profile with Contact Information, Plant Location, Capacity, Revenue 105
Figure Insulin of Merck 107
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Merck 2011-2016 107
Figure Biologics Revenue (M USD) and Growth Rate of Merck 2011-2016 108
Figure Biologics Revenue (M USD) and Global Market Share of Merck 2011-2016 108
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharma 2011-2016 110
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue 112
Figure Biologicas and Biosimilars Picture of 3sbio 113
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2011-2016 113
Figure Biologics Revenue (M USD) and Growth Rate of 3sbio 2011-2016 113
Figure Biologics Revenue (M USD) and Global Market Share of 3sbio 2011-2016 114
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue. 114
Figure Biologicas and Biosimilars Picture of Changchun High and New Technology Industry 115
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016 115
Figure Biologics Revenue (M USD) and Growth Rate of Changchun High Tech 2011-2016 116
Figure Biologics Revenue (M USD) and Global Market Share of 2011-2016 116
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue 117
Figure Biologicas and Biosimilars Picture of CP Guojian 118
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian 2011-2016 118
Figure Biologics Revenue (M USD) and Growth Rate of CP Guojian 2011-2016 119
Figure Biologics Revenue (M USD) and Global Market Share of CP Guojian 2011-2016 119
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue 120
Figure Biologicas and Biosimilars Picture of Biotech Pharma 121
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016 121
Figure Biologics Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016 122
Figure Biologics Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016 122
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue 123
Figure Biologicas and Biosimilars Picture of Gelgen Biopharma 124
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016 124
Figure Biologics Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016 125
Figure Biologics Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016 125
Table Innovent Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc. 126
Figure Biologicas and Biosimilars Picture of Innovent 127
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Innovent 2011-2016 127
Figure Biologics Revenue (M USD) and Growth Rate of Innovent 2011-2016 127
Figure Biologics Revenue (M USD) and Global Market Share of Innovent 2011-2016 128
Table Tong Hua Dong Bao Group Company Profile with Contact Information, Plant Location, Capacity, Revenue 128
Figure Insulin Picture of Tong Hua Dong Bao Group 129
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Tong Hua Dong Bao Group 2011-2016 129
Figure Biologics Revenue (M USD) and Growth Rate of Tong Hua Dong Bao Group 2011-2016 130
Figure Biologics Revenue (M USD) and Global Market Share of Tong Hua Dong Bao Group 2011-2016 130
Table Ganlee Company Profile with Contact Information, Plant Location, Capacity, Revenue 131
Table Insulin Picture of Ganlee 132
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Ganlee 2011-2016 132
Figure Biologics Revenue (M USD) and Growth Rate of Ganlee 2011-2016 132
Figure Biologics Revenue (M USD) and Global Market Share of Ganlee 2011-2016 133
Table United Laboratories Company Profile with Contact Information, Plant Location, Capacity, Revenue 133
Figure Insulin Picture of United Laboratories 135
Table Biologics Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of United Laboratories 2011-2016 135
Figure Biologics Revenue (M USD) and Growth Rate of United Laboratories 2011-2016 136
Figure Biologics Revenue (M USD) and Global Market Share of United Laboratories 2011-2016 136
Figure Biosimilars Picture of SANDOZ 138
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of SANDOZ 2011-2016 138
Figure Biosimilars Revenue (M USD) and Growth Rate of SANDOZ 2011-2016 139
Table Teva Company Profile 140
Figure Biosimilars Picture of Teva 141
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Teva 2011-2016 141
Figure Biosimilars Revenue (M USD) and Growth Rate of Teva 2011-2016 142
Figure Biosimilars Revenue (M USD) and Global Market Share of Teva 2011-2016 142
Table Hospira Company Profile 143
Figure Biosimilars Picture of Hospira 144
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Hospira 2011-2016 144
Figure Biosimilars Revenue (M USD) and Growth Rate of Hospira 2011-2016 145
Figure Biosimilars Revenue (M USD) and Global Market Share of Hospira 2011-2016 145
Figure Biosimilars Picture of MYLAN 147
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of MYLAN 2011-2016 147
Figure Biosimilars Revenue (M USD) and Growth Rate of MYLAN 2011-2016 148
Figure Biosimilars Revenue (M USD) and Global Market Share of MYLAN 2011-2016 148
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Sun Pharma 2011-2016 150
Figure Biosimilars Revenue (M USD) and Growth Rate of Sun Pharma 2011-2016 151
Figure Biosimilars Revenue (M USD) and Global Market Share of Sun Pharma 2011-2016 151
Table 3sbio Company Profile with Contact Information, Plant Location, Capacity, Revenue 152
Figure Biosimilars Picture of 3sbio 153
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of 3sbio 2011-2016 153
Figure Biosimilars Revenue (M USD) and Growth Rate of 3sbio 2011-2016 154
Figure Biosimilars Revenue (M USD) and Global Market Share of 3sbio 2011-2016 154
Table Changchun High Tech Company Profile with Contact Information, Plant Location, Capacity, Revenue. 155
Figure Biosimilars Picture of Changchun High and New Technology Industry 156
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016 156
Figure Biosimilars Revenue (M USD) and Growth Rate of Changchun High Tech 2011-2016 156
Figure Biosimilars Revenue (M USD) and Global Market Share of Changchun High Tech 2011-2016 157
Table CP Guojian Pharmacy Company Profile with Contact Information, Plant Location, Capacity, Revenue 157
Figure Biosimilars Picture of CP Guojian Pharmacy 158
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016 158
Figure Biosimilars Revenue (M USD) and Growth Rate of CP Guojian Pharmacy 2011-2016 159
Figure CP Guojian Pharmacy Biosimilars Revenue (M USD) and Global Market Share of 2011-2016 159
Table Biotech Pharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc. 160
Figure Biosimilars Picture of Biotech Pharma 161
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016 161
Figure Biosimilars Revenue (M USD) and Growth Rate of Biotech Pharma 2011-2016 162
Figure Biosimilars Revenue (M USD) and Global Market Share of Biotech Pharma 2011-2016 162
Table Gelgen Biopharma Company Profile with Contact Information, Plant Location, Capacity, Revenue, etc. 163
Figure Biosimilars Picture of Gelgen Biopharma 164
Table Biosimilars Cost (M USD), Gross (M USD), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016 164
Figure Biosimilars Revenue (M USD) and Growth Rate of Gelgen Biopharma 2011-2016 165
Figure Biosimilars Revenue (M USD) and Global Market Share of Gelgen Biopharma 2011-2016 165
Figure Global Revenue Market Share of Biologics and Biosimilar by Regions in 2014 167
Figure Global Consumption Market Share of Biologics and Biosimilar by Regions in 2014 168
Table Gross Margin of Global Regions 2011-2016 168
Table Gross Margin of Different Biologics and Biosimilars Applications 168
Figure Biologics and Biosimilars Domestic Marketing Channels Status 169
Figure Imported Biologics and Biosimilars Marketing Channels Status 170
Table Regional Import, Export, and Trade of Biologics (M USD) 171
Table Regional Import, Export, and Trade of Biosimilars (M USD) 171
Figure Global Revenue (M USD) and Growth Rate of Biologics 2016-2021 173
Figure Global Revenue (M USD) and Growth Rate Biosimilars 2016-2021 173
Figure China Revenue (M USD) and Growth Rate of Biologics 2016-2021 174
Figure China Revenue (M USD) and Growth Rate of Biosimilars 2016-2021 174
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2016 175
Figure Global Revenue Market Share of Major Biologics and Biosimilars Manufacturers in 2021 176
Figure Revenue Market Share of China Major Biologics and Biosimilars Manufacturers in 2016 177
Figure Revenue Market Share of China Major Biologics and Biosimilars Manufacturers in 2021 177
Figure Global and China Sales (M USD) and Growth Rate of Biologics 2016-2021 178
Figure Global and China Sales (M USD) and Growth Rate of Biosimilars 2016-2021 178
Table Global Supply, Sales and Gap of Biologics 2016-2021 (M USD) 179
Table China Supply, Sales and Gap of Biologics 2016-2021 (M USD) 179
Table Global Supply, Sales and Gap of Biosimilars 2016-2021 (M USD) 179
Table China Supply, Sales and Gap of Biosimilars 2016-2021 (M USD) 179
Table China Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (M USD) 180
Table China Production, Import, Export and Consumption of Biologics and Biosimilars 2016-2021 (M USD) 180
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021 180
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021 180
Table Global Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021 181
Table China Cost (M USD), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2016-2021 181
Table Manufacturing Equipment Suppliers of Biologicas and Biosimilars with Contact Information 182
Table Major Suppliers of Biologicas and Biosimilars with Contact Information 182
Table Key Consumers of Biologicas and Biosimilars with Contact Information 183
Figure Supply Chain Relationship Analysis of Biologics and Biosimilars 184
Figure Supply Chain Relationship Analysis of Biologicas and Biosimilars 184
Table Biologics and Biosimilars New Project SWOT Analysis for Chinese Company 185
Table New Project Investment Feasibility Analysis of Biologics and Biosimilars 186
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
